Harrow Inc reports results for the quarter ended June 30 - Earnings Summary

• Harrow Inc HROW.OQ reported quarterly adjusted earnings of 13 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -18 cents. The mean expectation of eight analysts for the quarter was for earnings of one cent per share. Wall Street expected results to range from -8 cents to 9 cents per share.

• Revenue rose 30.2% to $63.74 million from a year ago; analysts expected $66.00 million.

• Harrow Inc's reported EPS for the quarter was 13 cents​.

• The company reported quarterly net income of $5 million.

• Harrow Inc shares had risen by 12.7% this quarter and gained 2.6% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 82.6% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

• Wall Street's median 12-month price target for Harrow Inc is $60.00, about 42.6% above its last closing price of $34.43

This summary was machine generated from LSEG data August 11 at 09:00 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)